R. Wachter, J. Luce, J. Turner, P. Volberding, and P. Hopewell, Intensive Care of Patients with the Acquired Immunodeficiency Syndrome. Outcome and Changing Patterns of Utilization, Survey of Anesthesiology, vol.XXXI, issue.4, pp.891-896, 1986.
DOI : 10.1097/00132586-198708000-00053

R. Wachter, M. Russi, D. Bloch, P. Hopewell, and J. Luce, Pneumonia and Respiratory Failure in AIDS: Improved Outcomes and Increased Use of Intensive Care Units, American Review of Respiratory Disease, vol.143, issue.2, pp.251-256, 1991.
DOI : 10.1164/ajrccm/143.2.251

J. Bedos, C. Chastang, J. Lucet, T. Kalo, B. Gachot et al., Early Predictors of Outcome for HIV Patients With Neurological Failure, JAMA: The Journal of the American Medical Association, vol.273, issue.1, pp.35-40, 1995.
DOI : 10.1001/jama.1995.03520250051033

M. Thyrault, B. Gachot, C. Chastang, B. Souweine, J. Timsit et al., Septic shock in patients with the acquired immunodeficiency syndrome, Intensive Care Medicine, vol.23, issue.10, pp.1018-1023, 1997.
DOI : 10.1007/s001340050451

R. Nuesch, N. Geigy, E. Schaedler, and M. Battegay, Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients, Eur J Clin Microbiol Infect Dis, vol.21, pp.684-687, 2002.

A. Morris, R. Wachter, J. Luce, J. Turner, and L. Huang, Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia, AIDS, vol.17, issue.1, pp.73-80, 2003.
DOI : 10.1097/00002030-200301030-00010

B. Vincent, J. Timsit, M. Auburtin, F. Schortgen, L. Bouadma et al., Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era, Intensive Care Medicine, vol.30, issue.5, pp.859-866, 2004.
DOI : 10.1007/s00134-004-2158-z

K. Powell, J. Davis, A. Morris, A. Chi, M. Bensley et al., Survival for Patients With HIV Admitted to the ICU Continues to Improve in the Current Era of Combination Antiretroviral Therapy, Chest, vol.135, issue.1, pp.11-17, 2009.
DOI : 10.1378/chest.08-0980

I. Coquet, J. Pavie, P. Palmer, F. Barbier, S. Legriel et al., Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era, Critical Care, vol.14, issue.3, p.107, 2010.
DOI : 10.1186/cc9056

L. Huang, A. Quartin, D. Jones, and D. Havlir, Intensive Care of Patients with HIV Infection, New England Journal of Medicine, vol.355, issue.2, pp.173-181, 2006.
DOI : 10.1056/NEJMra050836

G. Nickas and R. Wachter, Outcomes of Intensive Care for Patients With Human Immunodeficiency Virus Infection, Archives of Internal Medicine, vol.160, issue.4, pp.541-547, 2000.
DOI : 10.1001/archinte.160.4.541

B. Afessa and B. Green, Clinical Course, Prognostic Factors, and Outcome Prediction for HIV Patients in the ICU, Chest, vol.118, issue.1, pp.138-145, 2000.
DOI : 10.1378/chest.118.1.138

C. Alves, J. Nicolas, J. Miro, A. Torres, C. Agusti et al., Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients, European Respiratory Journal, vol.17, issue.1, pp.87-93, 2001.
DOI : 10.1183/09031936.01.17100870

Y. Vargas-infante, M. Guerrero, G. Ruiz-palacios, L. Soto-ramirez, D. Rio et al., Improving Outcome of Human Immunodeficiency Virus-Infected Patients in a Mexican Intensive Care Unit, Archives of Medical Research, vol.38, issue.8, pp.827-833, 2007.
DOI : 10.1016/j.arcmed.2007.05.007

A. Morris, J. Creasman, J. Turner, J. Luce, R. Wachter et al., Intensive Care of Human Immunodeficiency Virus???infected Patients during the Era of Highly Active Antiretroviral Therapy, American Journal of Respiratory and Critical Care Medicine, vol.166, issue.3, pp.262-267, 2002.
DOI : 10.1164/rccm.2111025

M. Narasimhan, A. Posner, V. Depalo, P. Mayo, and M. Rosen, Intensive Care in Patients With HIV Infection in the Era of Highly Active Antiretroviral Therapy, Chest, vol.125, issue.5, pp.1800-1804, 2004.
DOI : 10.1378/chest.125.5.1800

J. Croda, M. Croda, A. Neves, D. Santos, and S. , Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit, Critical Care Medicine, vol.37, issue.5, pp.1605-1611, 2009.
DOI : 10.1097/CCM.0b013e31819da8c7

R. Miller, E. Allen, A. Copas, M. Singer, and S. Edwards, Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy, Thorax, vol.61, issue.8, pp.716-721, 2006.
DOI : 10.1136/thx.2005.055905

S. Dickson, S. Batson, A. Copas, S. Edwards, M. Singer et al., Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy, Thorax, vol.62, issue.11, pp.964-968, 2007.
DOI : 10.1136/thx.2006.072256

H. Khouli, A. Afrasiabi, M. Shibli, R. Hajal, C. Barrett et al., Outcome of Critically Ill Human Immunodeficiency Virus-Infected Patients in the Era of Highly Active Antiretroviral Therapy, Journal of Intensive Care Medicine, vol.14, issue.17, pp.327-333, 2005.
DOI : 10.1177/0885066605281087

S. Van-lelyveld, C. Wind, T. Mudrikova, H. Van-leeuwen, D. De-lange et al., Short- and long-term outcome of HIV-infected patients??admitted to the intensive care unit, European Journal of Clinical Microbiology & Infectious Diseases, vol.27, issue.9, pp.1085-1093, 2011.
DOI : 10.1007/s10096-011-1196-z

C. Lewden, G. Chene, P. Morlat, F. Raffi, M. Dupon et al., HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population, J Acquir Immune Defic Syndr, vol.46, pp.72-77, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00170726

S. Grabar, L. Moing, V. Goujard, C. Egger, M. Leport et al., Response to Highly Active Antiretroviral Therapy at 6 Months and Long-Term Disease Progression in HIV-1 Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.39, issue.3, pp.284-292, 2005.
DOI : 10.1097/01.qai.0000160925.33935.72

S. Grabar, L. Moing, V. Goujard, C. Leport, C. Kazatchkine et al., Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy, Annals of Internal Medicine, vol.133, issue.6, pp.401-410, 2000.
DOI : 10.7326/0003-4819-133-6-200009190-00007

M. Thompson, J. Aberg, P. Cahn, J. Montaner, G. Rizzardini et al., Antiretroviral Treatment of Adult HIV Infection, JAMA, vol.304, issue.3, pp.321-333, 2010.
DOI : 10.1001/jama.2010.1004

E. Casalino, M. Wolff, P. Ravaud, C. Choquet, F. Bruneel et al., Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit, AIDS, vol.18, issue.10, pp.1429-1433, 2004.
DOI : 10.1097/01.aids.0000131301.55204.a7

A. Morris, H. Masur, and L. Huang, Current issues in critical care of the human immunodeficiency virus-infected patient*, Critical Care Medicine, vol.34, issue.1, pp.42-49, 2006.
DOI : 10.1097/01.CCM.0000194539.50905.81

A. Zolopa and L. Komarow, Immediate versus deferred ART in the setting of acute AIDS-related OI: final results of a randomized strategy trial: ACTG A5164, p.15, 2008.